The 63rd Sesssion of the Commission on Narcotic Drugs takes place from 2nd to 6th March 2020. TNI and its partners will participate at this annual series of meetings and co-hosts five side events on 5th and 6th March 2020.
Societies in the Americas have coexisted with smokable cocaines for over four decades, but - surprisingly - there is a dearth of research on the development of the market, or much first-hand evidence of how this substance is actually commercialized and used by millions of people in the region. After a few years of field research, our study on the topic will be launched at the Commission on Narcotic Drugs.
As a growing number of countries move towards legal regulation for non-medical cannabis, governments are pushing the boundaries of the three UN drug control treaties. At the 61st session of the Commission on Narcotic Drugs (CND), TNI will co-organise a side event to explore the issue, addressing the various challenges and opportunities involved.
The Lancet - On April 19–21, 2016, the UN General Assembly Special Session on Drugs (UNGASS) will convene to chart a course for the future to tackle the world's drugs problem. The 2016 UNGASS represents a rare opportunity to reassess the global approach to drugs and to move towards drug policies that more effectively address the three UN pillars of peace and security, human development, and human rights. We believe that we need a new consensus that includes a commitment to revise the range of indicators used to assess and improve drug policy effectiveness.
China is proposing there should be a worldwide ban on ketamine - the class B drug that can lead to users needing to have their bladders removed. But ketamine is used as an anaesthetic drug in much of Africa, and there are fears further international controls could affect medical usage too.
Country delegations to the UN Commission on Narcotic Drugs (CND) don’t usually vote on things… The protocol is that member states reach consensus on language and policy (often meaning that the final language reflects the lowest common denominator). Usually this diplomatic process works and delegates compromise. However, at the most recent inter-sessional meeting of the CND on 5th November, some delegates drew “red lines” and staked out non-negotiable positions on key issues.
The year 2012 is particularly fitting to discuss the future of the UN drug control conventions as it marks the 100th anniversary of the first fully-fledged multilateral agreement on drug control held in The Hague. Last year was the 50th anniversary of the legislative bedrock of the current treaty regime: the 1961 UN Single Convention on Narcotic Drugs. These historic moments highlight not only its longevity, but also represent appropriate moments to reflect on the continuing relevance of the existing drug control regime in its entirety for the contemporary era.
Wednesday, March 14, 2012 at 13:00, Mozart Room in the Vienna International Centre (VIC Restaurant - Ground Floor, F Building) invitation only
The 53rd Commission on Narcotic Drugs (CND) was a rather uneventful event. After the High Level Segment in 2009, the final agreement on the new Political Declaration and the unprecedented addition of an Interpretative Statement on harm reduction, this year’s CND would be a generally low-key affair. One of the most controversial issues were the comments of the International Narcotics Control Board (INCB) on the trend to decriminalize possession for personal use in Argentina, Brazil and Mexico. Both Argentina and Mexico voiced strong objections. This CND also was marked by the imminent departure of Mr. Costa as Executive Director of the nited Nations Office on Drugs and Crime (UNODC).
The 2009 Commission on Narcotic Drugs and its High Level Segment (HLS) marked the end of the 2-year process of the 10-year review of the 1998 United Nations General Assembly Special Session (UNGASS) on the World Drug Problem. The event was marked by the call of the President of Bolivia, Evo Morales, to remove the coca leaf from the Single Convention on Narcotic Drugs, which represented the first ever truly open challenge by any nation state to the structure of the international drug control system. The HLS adopted a new Political Declaration and Plan of Action. A dissenting Interpretative Statement by 26 countries on harm reduction, not mentioned in the Political Declaration, marked a clear divide in drug control approaches.
The 51st Commission on Narcotic Drugs (CND) was designated as the point at which the international community would debate the progress made in the 10 years since the Political Declaration of the 1998 UN General Assembly Special Session on Drugs (UNGASS). The 1998 UNGASS called for the eradication or significant reduction of the cultivation, supply and demand of illicit drugs. Few governments acknowledged the real policy dilemmas arising from the failure to achieve these reductions, or came forward with proposals on how the international drug control system could be improved. One of the most debated issues was a resolution on human rights and international drug control introduced by Uruguay.
The 50th Commission on Narcotic Drugs (CND) was the last such event before the watershed year of 2008, when the international community will review progress against the objectives set at the General Assembly Special Session on Drugs (UNGASS), held in New York in 1998. This CND was notable for a significant improvement in civil society involvement in the proceedings – there were a record 81 civil society delegates and NGO representatives included in government delegations. On the other hand, there were repeated moves by some country delegations to marginalise NGO involvement. The global consultation with NGOs to feed in to the UNGASS review process as formally launched.